Salasayo, Arcely .
HRN: 27-68-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2025
CEFOTAXIME 500MG (VIAL)
08/23/2025
08/30/2025
PO
1 Tab
BID
S/P Ex Lap Salpingectomy Left
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines